Effective inhibition of dengue virus replication using 3′UTR-targeted Vivo-Morpholinos
IntroductionDue to the impact of antibody-dependent enhancement and viral variation, effective vaccines or antiviral therapies remain lacking for the dengue virus (DENV). Nucleic acid drugs, particularly Vivo-Morpholinos (MOs), have emerged as a promising avenue for antiviral treatment due to their...
Saved in:
| Main Authors: | Mengwei Niu, Wenyanbo Yi, Zhuofan Dong, Xiaofeng Li, Xue Dong, Lifang Yu, Yao Han, Oujia Zhang, Ziyang Sheng, Jing An, Hao Li, Yansong Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1491230/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01) -
LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01) -
Clinically relevant pseudoexons of the GALNS gene and their antisense-based correction
by: Igor Bychkov, et al.
Published: (2025-05-01) -
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe disease
by: Ryan A. Oliver, et al.
Published: (2025-06-01) -
Nucleic acid therapeutics: Past, present, and future
by: Sajid Naeem, et al.
Published: (2025-03-01)